News

Americans are buying THC seltzers at Total Wine while Congress debates re-criminalizing them. RYTHM’s blowout quarter shows who’s winning.

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

The packaged-food company now expects organic sales to fall 0.5% to 2.0% for the year, an improvement from its prior outlook

Investing.com - U.S. stock index futures were broadly higher on Wednesday as investors drew cautious optimism from signs that negotiations to reopen the Strait of Hormuz could be gaining traction, although disappointing reactions to earnings from Advanced Micro Devices and privately held SpaceX tempered enthusiasm for technology shares.

One company is burning cash and bleeding from legal battles; the other generates $2 billion in free cash flow but trades at a steep premium.

Investing.com -- Bernstein upgraded Elf Beauty to Outperform from Market-Perform and nearly doubled its price target to $113 from $60, citing a stronger-than-expected start to the company’s newly launched hair care line.

The e-commerce platform posted 34% revenue growth in the second quarter and projected third-quarter growth above Wall Street expectations

Adjusted EPS of $2.06 topped estimates of $1.86, while the experiences segment posted 10% revenue growth to nearly $10 billion

Eli Lilly and Novo Nordisk, the world’s two largest makers of weight-loss and diabetes drugs, raised their full-year forecasts on the back of...

Clear Secure (NYSE:YOU) shares rose more than 6% in pre-market trading on Wednesday after the identity technology company reported second-quarter results that topped Wall Street expectations and issued stronger guidance for the months ahead. The company posted adjusted earnings of $0.

Microsoft stock is on a four-day winning streak after breaking out of a cup base at a pivot of 466.32 amid an earnings beat.

SanDisk shares have rocketed over 400% this year and traders are piling in ahead of a make-or-break earnings report, but the pre-announcement surge may have already priced in the good news.

CVS Health earnings surged past tepid forecasts after reporting its health benefit costs fell as a share of premiums. The pharmacy chain hiked its full-year outlook by a bit less than the Q2 beat. Analysts say that management's prudence in trying to grow its health benefits business let the company avoid the worst fallout from surprisingly strong medical care utilization.

Investing.com -- Shopify Inc. (NASDAQ: SHOP) reported second-quarter results that exceeded analyst expectations on both revenue and earnings, sending shares up 26% premarket as the company delivered accelerating growth across key metrics.

Shopify posted a surge in second-quarter profit, driven by gains across both its subscription software and merchant services units.

FTC Solar (FTCI) delivered earnings and revenue surprises of -55.10% and +6.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) delivered earnings and revenue surprises of +37.97% and +5.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Shopify stock tock soared as Q2 gross operating profit beat estimates amid worries over margin pressure from AI investments.

Eli Lilly posted a blockbuster second quarter fueled by continued demand for its portfolio of GLP-1 medications. The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.

Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates

CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share

Investing.com -- Shares of Circle Internet Group jumped 7% in premarket trading on Wednesday after the stablecoin issuer reported second-quarter earnings in line with estimates and disclosed it had received the first federal bank charter awarded to a stablecoin company.

Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.

Clear Secure (YOU) delivered earnings and revenue surprises of +22.50% and +2.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Canada's Shopify projected current-quarter revenue growth above Wall Street estimates on Wednesday, signaling the company's AI efforts were drawing more merchants ‌to its suite of e-commerce services, sending its U.S.-listed shares up 26% ‌premarket. The company's solid outlook and a second-quarter revenue beat are set to quell investor concerns about growing ​competition from new AI tools targeting small businesses that have dented Shopify's shares. If premarket gains hold, Shopify shares are set to recoup all losses this year.

Uber Technologies notched higher revenue in second quarter, driven by growth in its delivery business as the company continues to grow volumes and active users.

Kratos Defense & Security (NASDAQ:KTOS) shares jumped 7. 8% in pre-market trading after the defense technology company reported second-quarter 2026 results that comfortably exceeded Wall Street expectations and raised its growth outlook for the full year.

CVS Health said it will revamp its weight management program through a partnership with Eli Lilly as the company lifted its full-year outlook and reported a nearly threefold increase in its second-quarter profit.

Autonomous driving partner Wayve received a key London license, paving the way for public robotaxi trials on the platform.

General Motors (NYSE:GM) has renewed its joint venture with China’s SAIC Motor for another 20 years, marking a new chapter for the partnership after a major restructuring of its operations in the Chinese market that included factory closures and a streamlined vehicle lineup. The renewed agreement preserves the companies’ 50-50 ownership structure and places greater emphasis on developing vehicles within China to better meet the preferences of local consumers.